Sambial, Jeff P.
HRN: 22-93-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2023
CEFUROXIME 750MG (VIAL)
04/23/2023
04/30/2023
IV
250mg
Q8h
Age With Moderate Dhn
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes